Drug Eluting Stent (DES) Market Size, Share & Industry Analysis, By Type (Coronary Stenting, and Peripheral Stenting), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol and Others), By Drug (Sirolimus, Paclitaxel, Zotarolimus, Everolimus and Others), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI102612

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2021-2034
Base Year	2025
Forecast Period	2026-2034
Historical Period	2021-2024
Unit	Value (USD billion)
Segmentation	By Type Coronary Stenting Peripheral Stenting
	By Scaffold Cobalt-Chromium Platinum-Chromium Nitinol Others
	By Drug Sirolimus Paclitaxel Zotarolimus Everolimus Others
	By End User Hospitals Specialty Clinics
	By Geography North America (the U.S. and Canada) Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe) Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific) Latin America (Brazil, Mexico, and the Rest of Latin America) Middle East & Africa (South Africa, GCC and the Rest of Middle East & Africa)